Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.060 +0.107 (+11.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
34 35 Next >
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001. 
Via The Motley Fool
Exposures COVID-19
21 Stocks Moving in Monday's Pre-Market Session
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine... 
Via Benzinga
Exposures COVID-19
Is Ocugen Stock Heading for a Crash?
The stock soared more than 22% this past week. 
Via The Motley Fool
Exposures COVID-19
Why Shares of Moderna, Novavax, and Ocugen Are Falling Today
These COVID-19 vaccine makers are sinking on nothing more than good old-fashioned uncertainty. 
Via The Motley Fool
Exposures COVID-19 Product Safety
51 Biggest Movers From Friday
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it... 
Via Benzinga
Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success
Still, traders haven't given up; despite a mountain of bad news, OCGN stock inexplicably trades for nearly $10 per share. 
Via InvestorPlace
Topics Lawsuit
Exposures COVID-19 Financial Legal
Why Ocugen Stock Is Skyrocketing This Week
Positive developments for COVID-19 vaccine Covaxin appear to have kicked off a short squeeze. 
Via The Motley Fool
Exposures COVID-19
OCGN Stock: One Big Reason Why Ocugen Is Climbing Today
Covid-19 vaccine play Ocugen is seeing impressive investor interest today, with OCGN stock seeing double-digit gains at the time of writing. 
Via InvestorPlace
Exposures COVID-19
Ocugen Stock Needs a Catalyst for Growth That Probably Isn’t Coming
InvestorPlace’s Louis Navellier believes all Ocugen needs is a catalyst. OCGN stock got two. Its share price barely moved. 
Via InvestorPlace
45 Biggest Movers From Yesterday
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday’s regular trading session, extending gains to a second straight day. What... 
Via Benzinga
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd... 
Via Benzinga
Most Active Equity Options For Midday - Tuesday, Oct. 12
Top Tickers: TSLA, AAPL, FB, F, T, MU, PROG, SOFI, FCX, BABA, BBIG, WKHS, OCGN, NVDA, AMC, AMD, MGM, BAC, AMZN, NIO. 
Via Talk Markets
Benchmarks Muted After Slashed Global Growth Forecast
The major indexes are struggling for direction this afternoon after fresh data from the U.S. Labor Department showed job openings in August fell sharply to 10.4 million, while workers quit retail and... 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after... 
Via Benzinga
OCGN Stock: One Big Reason Ocugen Is Powering Higher Today
OCGN stock is making its investors quite happy this morning and prompting many more to pile in. The company is receiving crucial approval. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Stock Is on Fire Today
A positive regulatory development in India is sending the biotech's shares higher today. 
Via The Motley Fool
Exposures COVID-19
Why Ocugen's Stock Is Trading Higher Today
Ocugen Inc (NASDAQ: OCGN) is trading higher Tuesday after the Indian government approved Bharat Biotech's COVID-19 vaccine, Covaxin, for children between the age of... 
Via Benzinga
Exposures COVID-19
Ocugen Will Have Value If Its Covid Vaccine Can Get Approved
OCGN stock could be at a full value today given revenue prospects but could still rise if its Covaxin vaccine gains approval outside India. 
Via InvestorPlace
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock
The latest buzz around Covaxin does little to improve the prospects of OCGN stock, so buying it for this reason doesn't make much sense. 
Via InvestorPlace
Exposures COVID-19
Why Did Ocugen Stock Skyrocket On Monday?
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday’s regular trading session and also gained 11.4% in the after-hours session. What... 
Via Benzinga
OCUGEN INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ocugen, Inc. - OCGN
From Kahn Swick & Foti, LLC
Via Business Wire
WHO To Finalize Nod To Ocugen-Partnered Covaxin Next Week: Sources
The World Health Organization said a decision on the Emergency Use Listing (EUL) of India's COVID-19 vaccine, Covaxin, will be finalized next week. Ocugen Inc (... 
Via Benzinga
Exposures COVID-19
Ocugen Bulls Are Overlooking Its FDA Approval Hurdles
The FDA seems highly unlikely to approve the Covaxin vaccine, making OCGN stock an excellent name to short going forward. 
Via InvestorPlace
Exposures COVID-19 Product Safety
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Shares Are Trading Higher Today
Ocugen Inc (NASDAQ: OCGN) is trading higher Tuesday after a company 8-K showed it entered into a Development and Commercial Supply Agreement with Bharat Biotech pursuant to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4... 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.